Biofrontera Statistics
Biofrontera (AI10) Stock Statistics & Valuation Metrics
Total Valuation
Biofrontera has a market cap or net worth of EUR 12.59M. The enterprise value is EUR 15.06M.
- Market Cap
- EUR 12.59M
- Enterprise Value
- EUR 15.06M
Share Statistics
Biofrontera has 14,852,359 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 14,852,359
- Owned by Insiders
- 3.76%
- Owned by Institutions
- 11.63%
Financial Efficiency
Biofrontera’s return on equity (ROE) is -1.01 and return on invested capital (ROIC) is -53.81%.
- Return on Equity (ROE)
- -1.01
- Return on Assets (ROA)
- -0.37
- Return on Invested Capital (ROIC)
- -53.81%
- Return on Capital Employed (ROCE)
- -0.55
- Revenue Per Employee
- 468.60K
- Profits Per Employee
- -118.38K
- Employee Count
- 89
- Asset Turnover
- 1.46
- Inventory Turnover
- 6.24
Valuation Ratios
The current PE Ratio of Biofrontera is -1.54. Biofrontera’s PEG ratio is -0.01.
- PE Ratio
- -1.54
- PS Ratio
- 0.30
- PB Ratio
- 2.01
- Price to FCF
- -1.73
- Price to Operating Cash Flow
- -1.51
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Biofrontera had revenue of 41.70M and earned -10.54M in profits. Earnings per share was -1.04.
- Revenue
- 41.70M
- Gross Profit
- 32.80M
- Operating Income
- -9.15M
- Pretax Income
- -10.51M
- Net Income
- -10.54M
- EBITDA
- -9.19M
- Earnings Per Share (EPS)
- -1.04
Cash Flow
In the last 12 months, operating cash flow was -7.93M and capital expenditures -3,000, giving a free cash flow of -7.93M billion.
- Operating Cash Flow
- -7.93M
- Free Cash Flow
- -7.93M
- Free Cash Flow per Share
- -0.61
Dividends & Yields
Biofrontera pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -57.72%
- Earnings Yield
- -53.24%
Stock Price Statistics
- Beta
- ―
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.80
- 200-Day Moving Average
- 0.80
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Biofrontera upcoming earnings date is Mar 19, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 13, 2026
- Next Earnings Date
- Mar 19, 2027
- Ex-Dividend Date
- ―
Financial Position
Biofrontera as a current ratio of 1.52, with Debt / Equity ratio of 58.79%
- Current Ratio
- 1.52
- Quick Ratio
- 1.40
- Debt to Market Cap
- 1.01
- Net Debt to EBITDA
- 0.03
- Interest Coverage Ratio
- -20.24
Taxes
In the past 12 months, Biofrontera has paid 25.00K in taxes.
- Income Tax
- 25.00K
- Effective Tax Rate
- -0.00
Enterprise Valuation
Biofrontera EV to EBITDA ratio is -3.05, with an EV/FCF ratio of -2.09.
- EV to Sales
- 0.36
- EV to EBITDA
- -3.05
- EV to Free Cash Flow
- -2.09
- EV to Operating Cash Flow
- -2.09
Balance Sheet
Biofrontera has EUR 4.67M in cash and marketable securities with EUR 7.50M in debt, giving a net cash position of -EUR 2.84M billion.
- Cash & Marketable Securities
- EUR 4.67M
- Total Debt
- EUR 7.50M
- Net Cash
- -EUR 2.84M
- Net Cash Per Share
- -EUR 0.19
- Tangible Book Value Per Share
- EUR 0.26
Margins
Gross margin is 84.45%, with operating margin of -9.45%, and net profit margin of -13.78%.
- Gross Margin
- 84.45%
- Operating Margin
- -9.45%
- Pretax Margin
- -13.72%
- Net Profit Margin
- -13.78%
- EBITDA Margin
- -11.76%
- EBIT Margin
- -13.52%
